Wolfgang Staehle,Christos Tsaklakidis,Birgitta Leuthner,Dirk Wienke,Frank Czauderna,Ansgar Wegener
申请号：
US14430630
公开号：
US20150252046A1
申请日:
2013.08.30
申请国别(地区):
US
年份:
2015
代理人:
摘要：
Compounds of the formula Iin which R1, R2, R, X1, X2, X3, X4, n1, n2, n3 and n4 have the meanings indicated in Claim 1, are inhibitors of Tankyrase, and can be employed, inter alia, for the treatment of diseases such as cancer, cardiovascular diseases, central nervous system injury and different forms of inflammation.
